Application of the Subtractive Genomics and Molecular Docking Analysis for the Identification of Novel Putative Drug Targets against Salmonella enterica subsp. enterica serovar Poona

Abstract EN

The emergence of novel pathogenic strains with increased antibacterial resistance patterns poses a significant threat to the management of infectious diseases.

In this study, we aimed at utilizing the subtractive genomic approach to identify novel drug targets against Salmonella enterica subsp.

enterica serovar Poona strain ATCC BAA-1673.

We employed in silico bioinformatics tools to subtract the strain-specific paralogous and host-specific homologous sequences from the bacterial proteome.

The sorted proteome was further refined to identify the essential genes in the pathogenic bacterium using the database of essential genes (DEG).

We carried out metabolic pathway and subcellular location analysis of the essential proteins of the pathogen to elucidate the involvement of these proteins in important cellular processes.

We found 52 unique essential proteins in the target proteome that could be utilized as novel targets to design newer drugs.

Further, we investigated these proteins in the DrugBank databases and 11 of the unique essential proteins showed druggability according to the FDA approved drug bank databases with diverse broad-spectrum property.

Molecular docking analyses of the novel druggable targets with the drugs were carried out by AutoDock Vina option based on scoring functions.

The results showed promising candidates for novel drugs against Salmonella infections.